Skip to main content
. Author manuscript; available in PMC: 2022 Apr 19.
Published in final edited form as: Ann Neurol. 2021 Mar 4;89(5):942–951. doi: 10.1002/ana.26032

TABLE.

Polygenic Risk Score Results Stratified by Brain Cell Type

Data set Tissue Cell type R2 P Coefficient No. of SNPs
Training data set 7,218 PD 9,424 controls Brain Microglia 0.058 6.9e-163 0.48 1,032
Neurons 0.055 2.9e-152 0.46 886
Astrocytes 0.048 1.3e-134 0.43 847
Oligodendrocytes 0.050 9.0e-141 0.44 842
Immune Monocytes 0.084 1.4e-227 0.58 1,915
B cells 0.061 4.8e-168 0.49 1,049
CD4+ T cells 0.056 2.4e-156 0.47 890
CD8+ T cells 0.055 9.0e-153 0.46 888
Test data set 5,429 PD 5,814 controls Brain Microglia 0.029 6.1e-56 0.31 1,032
Neurons 0.024 3.6e-46 0.28 886
Oligodendrocytes 0.020 2.6e-39 0.26 842
Astrocytes 0.019 7.1e-37 0.25 847
Immune B cells 0.029 2.4e-54 0.31 1,049
CD4+ T cells 0.029 3.8e-54 0.31 890
CD8+ T cells 0.026 6.4e-49 0.29 888
Monocytes 0.026 1.7e-48 0.29 1,915

Association results of polygenic risk scores modeled on summary statistics from an independent genomewide association study and stratified to include variants within open chromatin regions for various cell types. Scores were generated using the PRSice software tool with a cutoff of p < 0.05 in the reference data. Within each dataset and tissue, results are ordered with the best performing model first.

SNPs = single-nucleotide polymorphisms.